<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>PILMAN &#187; poor</title>
	<atom:link href="http://www.tapanray.in/tag/poor/feed/" rel="self" type="application/rss+xml" />
	<link>http://www.tapanray.in</link>
	<description>A Tapan Ray Website</description>
	<lastBuildDate>Sun, 22 Mar 2026 10:59:18 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>http://wordpress.org/?v=3.4.2</generator>
		<item>
		<title>For Affordable Access To Quality Healthcare in India, Invest Where The Mouth Is</title>
		<link>http://www.tapanray.in/for-affordable-access-to-quality-healthcare-in-india-invest-where-the-mouth-is/?utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=for-affordable-access-to-quality-healthcare-in-india-invest-where-the-mouth-is</link>
		<comments>http://www.tapanray.in/for-affordable-access-to-quality-healthcare-in-india-invest-where-the-mouth-is/#comments</comments>
		<pubDate>Mon, 25 Mar 2019 00:00:59 +0000</pubDate>
		<dc:creator>Tapan Ray</dc:creator>
				<category><![CDATA[Pharma]]></category>
		<category><![CDATA[AB-NHPS]]></category>
		<category><![CDATA[Access]]></category>
		<category><![CDATA[affordable]]></category>
		<category><![CDATA[Ayushman Bharat Program]]></category>
		<category><![CDATA[benefits]]></category>
		<category><![CDATA[care]]></category>
		<category><![CDATA[doctor]]></category>
		<category><![CDATA[expenditure]]></category>
		<category><![CDATA[Government]]></category>
		<category><![CDATA[Health]]></category>
		<category><![CDATA[hospitalization]]></category>
		<category><![CDATA[India]]></category>
		<category><![CDATA[invest]]></category>
		<category><![CDATA[Modicare]]></category>
		<category><![CDATA[National Health Protection Scheme]]></category>
		<category><![CDATA[oop]]></category>
		<category><![CDATA[out of pocket]]></category>
		<category><![CDATA[Patient]]></category>
		<category><![CDATA[PHC]]></category>
		<category><![CDATA[poor]]></category>
		<category><![CDATA[population]]></category>
		<category><![CDATA[primary]]></category>
		<category><![CDATA[private]]></category>
		<category><![CDATA[Quality]]></category>
		<category><![CDATA[Ray]]></category>
		<category><![CDATA[Tapan]]></category>
		<category><![CDATA[Tapan Ray]]></category>
		<category><![CDATA[where the mouth is]]></category>

		<guid isPermaLink="false">http://www.tapanray.in/?p=9454</guid>
		<description><![CDATA[On September 25, 2018, well-hyped Ayushman Bharat &#8211; National Health Protection Scheme (AB-NHPS), touted as the largest health scheme in the world, was launched in India. Prior to its launch, while announcing the scheme on August 15, 2018 from the &#8230; <a href="http://www.tapanray.in/for-affordable-access-to-quality-healthcare-in-india-invest-where-the-mouth-is/">Continue reading <span class="meta-nav">&#8594;</span></a>]]></description>
		<wfw:commentRss>http://www.tapanray.in/for-affordable-access-to-quality-healthcare-in-india-invest-where-the-mouth-is/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>The top two reasons for not seeking medical treatment, across the population, are not poor ‘Access to Healthcare’ in India</title>
		<link>http://www.tapanray.in/the-top-two-reasons-for-not-seeking-medical-treatment-across-the-population-are-not-poor-access-to-healthcare-in-india/?utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=the-top-two-reasons-for-not-seeking-medical-treatment-across-the-population-are-not-poor-access-to-healthcare-in-india</link>
		<comments>http://www.tapanray.in/the-top-two-reasons-for-not-seeking-medical-treatment-across-the-population-are-not-poor-access-to-healthcare-in-india/#comments</comments>
		<pubDate>Mon, 07 Feb 2011 00:00:52 +0000</pubDate>
		<dc:creator>Tapan Ray</dc:creator>
				<category><![CDATA[Pharma]]></category>
		<category><![CDATA[Access]]></category>
		<category><![CDATA[Across]]></category>
		<category><![CDATA[Affordability]]></category>
		<category><![CDATA[are]]></category>
		<category><![CDATA[awareness]]></category>
		<category><![CDATA[delivery]]></category>
		<category><![CDATA[for]]></category>
		<category><![CDATA[Healthcare]]></category>
		<category><![CDATA[in]]></category>
		<category><![CDATA[India]]></category>
		<category><![CDATA[infrastructure]]></category>
		<category><![CDATA[Medical]]></category>
		<category><![CDATA[Medicines]]></category>
		<category><![CDATA[Not]]></category>
		<category><![CDATA[Pharmaceuticals]]></category>
		<category><![CDATA[poor]]></category>
		<category><![CDATA[population]]></category>
		<category><![CDATA[Ray]]></category>
		<category><![CDATA[reasons]]></category>
		<category><![CDATA[rich]]></category>
		<category><![CDATA[rural]]></category>
		<category><![CDATA[seeking]]></category>
		<category><![CDATA[Tapan]]></category>
		<category><![CDATA[the]]></category>
		<category><![CDATA[to]]></category>
		<category><![CDATA[top]]></category>
		<category><![CDATA[treatment]]></category>
		<category><![CDATA[two]]></category>
		<category><![CDATA[urban]]></category>

		<guid isPermaLink="false">http://tapanray.in/index.php/?p=305</guid>
		<description><![CDATA[“About 1.8 million children under age of 5 die in India every year; 68,000 mothers die due to maternal causes, and 52 million children in the country are stunted”. “With 70% people living in more than 600,000 villages across rural &#8230; <a href="http://www.tapanray.in/the-top-two-reasons-for-not-seeking-medical-treatment-across-the-population-are-not-poor-access-to-healthcare-in-india/">Continue reading <span class="meta-nav">&#8594;</span></a>]]></description>
		<wfw:commentRss>http://www.tapanray.in/the-top-two-reasons-for-not-seeking-medical-treatment-across-the-population-are-not-poor-access-to-healthcare-in-india/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Non-Communicable Diseases (NCD) are hitting the poor even harder, economically: a time to ponder and a time to act</title>
		<link>http://www.tapanray.in/non-communicable-diseases-ncd-are-hitting-the-poor-even-harder-economically-a-time-to-ponder-and-a-time-to-act/?utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=non-communicable-diseases-ncd-are-hitting-the-poor-even-harder-economically-a-time-to-ponder-and-a-time-to-act</link>
		<comments>http://www.tapanray.in/non-communicable-diseases-ncd-are-hitting-the-poor-even-harder-economically-a-time-to-ponder-and-a-time-to-act/#comments</comments>
		<pubDate>Mon, 06 Dec 2010 00:30:39 +0000</pubDate>
		<dc:creator>Tapan Ray</dc:creator>
				<category><![CDATA[Pharma]]></category>
		<category><![CDATA[a]]></category>
		<category><![CDATA[Access]]></category>
		<category><![CDATA[Act]]></category>
		<category><![CDATA[Affordability]]></category>
		<category><![CDATA[and]]></category>
		<category><![CDATA[are]]></category>
		<category><![CDATA[Communicable]]></category>
		<category><![CDATA[Cost]]></category>
		<category><![CDATA[diseases]]></category>
		<category><![CDATA[drugs]]></category>
		<category><![CDATA[economically]]></category>
		<category><![CDATA[Even]]></category>
		<category><![CDATA[harder]]></category>
		<category><![CDATA[hitting]]></category>
		<category><![CDATA[Medicines]]></category>
		<category><![CDATA[NCD]]></category>
		<category><![CDATA[Non]]></category>
		<category><![CDATA[Pharmaceuticals]]></category>
		<category><![CDATA[ponder]]></category>
		<category><![CDATA[poor]]></category>
		<category><![CDATA[price]]></category>
		<category><![CDATA[Ray]]></category>
		<category><![CDATA[Tapan]]></category>
		<category><![CDATA[the]]></category>
		<category><![CDATA[time]]></category>
		<category><![CDATA[to]]></category>
		<category><![CDATA[WHO]]></category>

		<guid isPermaLink="false">http://tapanray.in/index.php/?p=339</guid>
		<description><![CDATA[November 11, 2010 edition of &#8216;The Lancet&#8217; published an article titled, “Raising the priority of preventing chronic diseases: a political process&#8221;. The article enumerated the following: “Chronic diseases, especially cardiovascular diseases, diabetes, cancer, and chronic obstructive respiratory diseases, are neglected &#8230; <a href="http://www.tapanray.in/non-communicable-diseases-ncd-are-hitting-the-poor-even-harder-economically-a-time-to-ponder-and-a-time-to-act/">Continue reading <span class="meta-nav">&#8594;</span></a>]]></description>
		<wfw:commentRss>http://www.tapanray.in/non-communicable-diseases-ncd-are-hitting-the-poor-even-harder-economically-a-time-to-ponder-and-a-time-to-act/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Open Source Drug Discovery (OSDD) initiative for the tropical diseases by CSIR and cancer by GlaxoSmithKline deserves a big applaud and support from all concerned.</title>
		<link>http://www.tapanray.in/open-source-drug-discovery-osdd-initiative-for-the-tropical-diseases-by-csir-and-cancer-by-glaxosmithkline-deserves-a-big-applaud-and-support-from-all-concerned/?utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=open-source-drug-discovery-osdd-initiative-for-the-tropical-diseases-by-csir-and-cancer-by-glaxosmithkline-deserves-a-big-applaud-and-support-from-all-concerned</link>
		<comments>http://www.tapanray.in/open-source-drug-discovery-osdd-initiative-for-the-tropical-diseases-by-csir-and-cancer-by-glaxosmithkline-deserves-a-big-applaud-and-support-from-all-concerned/#comments</comments>
		<pubDate>Thu, 03 Dec 2009 01:00:31 +0000</pubDate>
		<dc:creator>Tapan Ray</dc:creator>
				<category><![CDATA[Pharma]]></category>
		<category><![CDATA[a]]></category>
		<category><![CDATA[Access]]></category>
		<category><![CDATA[Affordability]]></category>
		<category><![CDATA[All]]></category>
		<category><![CDATA[and]]></category>
		<category><![CDATA[applaud]]></category>
		<category><![CDATA[big]]></category>
		<category><![CDATA[by]]></category>
		<category><![CDATA[cancer]]></category>
		<category><![CDATA[concerned]]></category>
		<category><![CDATA[CSIR]]></category>
		<category><![CDATA[deserves]]></category>
		<category><![CDATA[Developing]]></category>
		<category><![CDATA[discovery]]></category>
		<category><![CDATA[diseases]]></category>
		<category><![CDATA[Drug]]></category>
		<category><![CDATA[for]]></category>
		<category><![CDATA[From]]></category>
		<category><![CDATA[GlaxoSmithKline]]></category>
		<category><![CDATA[GSK]]></category>
		<category><![CDATA[Initiative]]></category>
		<category><![CDATA[OSDD]]></category>
		<category><![CDATA[Patent]]></category>
		<category><![CDATA[Pharmaceuticals]]></category>
		<category><![CDATA[pool. Open]]></category>
		<category><![CDATA[poor]]></category>
		<category><![CDATA[price]]></category>
		<category><![CDATA[Ray]]></category>
		<category><![CDATA[source]]></category>
		<category><![CDATA[support]]></category>
		<category><![CDATA[Tapan]]></category>
		<category><![CDATA[the]]></category>
		<category><![CDATA[tropical]]></category>

		<guid isPermaLink="false">http://tapanray.in/index.php/?p=709</guid>
		<description><![CDATA[As the name suggest the ‘Open Source Drug Discovery (OSDD)’ is an open source code model of discovering a New Chemical Entity (NCE) or a New Molecular Entity (NME). In this model all data generated related to the discovery research will be &#8230; <a href="http://www.tapanray.in/open-source-drug-discovery-osdd-initiative-for-the-tropical-diseases-by-csir-and-cancer-by-glaxosmithkline-deserves-a-big-applaud-and-support-from-all-concerned/">Continue reading <span class="meta-nav">&#8594;</span></a>]]></description>
		<wfw:commentRss>http://www.tapanray.in/open-source-drug-discovery-osdd-initiative-for-the-tropical-diseases-by-csir-and-cancer-by-glaxosmithkline-deserves-a-big-applaud-and-support-from-all-concerned/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>India urgently needs a total overhaul and reform of its public healthcare system with a holistic approach – NRHM and RSBY are laudable initiatives.</title>
		<link>http://www.tapanray.in/india-urgently-needs-a-total-overhaul-and-reform-of-its-public-healthcare-system-with-a-holistic-approach-nrhm-and-rsby-are-laudable-initiatives/?utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=india-urgently-needs-a-total-overhaul-and-reform-of-its-public-healthcare-system-with-a-holistic-approach-nrhm-and-rsby-are-laudable-initiatives</link>
		<comments>http://www.tapanray.in/india-urgently-needs-a-total-overhaul-and-reform-of-its-public-healthcare-system-with-a-holistic-approach-nrhm-and-rsby-are-laudable-initiatives/#comments</comments>
		<pubDate>Mon, 30 Nov 2009 01:30:18 +0000</pubDate>
		<dc:creator>Tapan Ray</dc:creator>
				<category><![CDATA[Pharma]]></category>
		<category><![CDATA[a]]></category>
		<category><![CDATA[Access]]></category>
		<category><![CDATA[affordable]]></category>
		<category><![CDATA[and]]></category>
		<category><![CDATA[Approach]]></category>
		<category><![CDATA[are]]></category>
		<category><![CDATA[BPL]]></category>
		<category><![CDATA[delivery]]></category>
		<category><![CDATA[Healthcare]]></category>
		<category><![CDATA[holistic]]></category>
		<category><![CDATA[India]]></category>
		<category><![CDATA[infrastructure]]></category>
		<category><![CDATA[initiatives]]></category>
		<category><![CDATA[its]]></category>
		<category><![CDATA[Laudable]]></category>
		<category><![CDATA[needs]]></category>
		<category><![CDATA[NRHM]]></category>
		<category><![CDATA[of]]></category>
		<category><![CDATA[overhaul]]></category>
		<category><![CDATA[Pharmaceuticals]]></category>
		<category><![CDATA[poor]]></category>
		<category><![CDATA[PPP]]></category>
		<category><![CDATA[price]]></category>
		<category><![CDATA[public]]></category>
		<category><![CDATA[Ray]]></category>
		<category><![CDATA[Reform]]></category>
		<category><![CDATA[RSBY]]></category>
		<category><![CDATA[system]]></category>
		<category><![CDATA[Tapan]]></category>
		<category><![CDATA[total]]></category>
		<category><![CDATA[urgently]]></category>
		<category><![CDATA[with]]></category>

		<guid isPermaLink="false">http://tapanray.in/index.php/?p=712</guid>
		<description><![CDATA[Over a period of time India had made significant improvement in various critical health indicators despite frugal public health spending by the government, which is just around 1 percent of GDP of the country. Such a low government spend towards &#8230; <a href="http://www.tapanray.in/india-urgently-needs-a-total-overhaul-and-reform-of-its-public-healthcare-system-with-a-holistic-approach-nrhm-and-rsby-are-laudable-initiatives/">Continue reading <span class="meta-nav">&#8594;</span></a>]]></description>
		<wfw:commentRss>http://www.tapanray.in/india-urgently-needs-a-total-overhaul-and-reform-of-its-public-healthcare-system-with-a-holistic-approach-nrhm-and-rsby-are-laudable-initiatives/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Healthcare reform for the needy and poor in the richest and the most populous countries of the world. What about the largest democracy of our planet?</title>
		<link>http://www.tapanray.in/healthcare-reform-for-the-needy-and-poor-in-the-richest-and-the-most-populous-countries-of-the-world-what-about-the-largest-democracy-of-our-planet/?utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=healthcare-reform-for-the-needy-and-poor-in-the-richest-and-the-most-populous-countries-of-the-world-what-about-the-largest-democracy-of-our-planet</link>
		<comments>http://www.tapanray.in/healthcare-reform-for-the-needy-and-poor-in-the-richest-and-the-most-populous-countries-of-the-world-what-about-the-largest-democracy-of-our-planet/#comments</comments>
		<pubDate>Thu, 17 Sep 2009 01:00:30 +0000</pubDate>
		<dc:creator>Tapan Ray</dc:creator>
				<category><![CDATA[Pharma]]></category>
		<category><![CDATA[about]]></category>
		<category><![CDATA[Access]]></category>
		<category><![CDATA[Affordability]]></category>
		<category><![CDATA[and]]></category>
		<category><![CDATA[China]]></category>
		<category><![CDATA[countries]]></category>
		<category><![CDATA[delivery]]></category>
		<category><![CDATA[democracy]]></category>
		<category><![CDATA[doctors]]></category>
		<category><![CDATA[for]]></category>
		<category><![CDATA[Healthcare]]></category>
		<category><![CDATA[hospitals]]></category>
		<category><![CDATA[in]]></category>
		<category><![CDATA[India]]></category>
		<category><![CDATA[infrastructure]]></category>
		<category><![CDATA[largest]]></category>
		<category><![CDATA[most]]></category>
		<category><![CDATA[needy]]></category>
		<category><![CDATA[of]]></category>
		<category><![CDATA[our]]></category>
		<category><![CDATA[Pharmaceuticals]]></category>
		<category><![CDATA[plane]]></category>
		<category><![CDATA[poor]]></category>
		<category><![CDATA[populous]]></category>
		<category><![CDATA[price]]></category>
		<category><![CDATA[Ray]]></category>
		<category><![CDATA[Reform]]></category>
		<category><![CDATA[richest]]></category>
		<category><![CDATA[Tapan]]></category>
		<category><![CDATA[the]]></category>
		<category><![CDATA[USA]]></category>
		<category><![CDATA[what]]></category>
		<category><![CDATA[World]]></category>

		<guid isPermaLink="false">http://tapanray.in/index.php/?p=777</guid>
		<description><![CDATA[Healthcare reform to ensure access to affordable high quality healthcare services for all, is considered as an integral part of the economic progress of any country. During recent global financial meltdown, this need became visible all over the world, even &#8230; <a href="http://www.tapanray.in/healthcare-reform-for-the-needy-and-poor-in-the-richest-and-the-most-populous-countries-of-the-world-what-about-the-largest-democracy-of-our-planet/">Continue reading <span class="meta-nav">&#8594;</span></a>]]></description>
		<wfw:commentRss>http://www.tapanray.in/healthcare-reform-for-the-needy-and-poor-in-the-richest-and-the-most-populous-countries-of-the-world-what-about-the-largest-democracy-of-our-planet/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Witty promise – is it path breaking?</title>
		<link>http://www.tapanray.in/witty-promise-is-it-path-breaking/?utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=witty-promise-is-it-path-breaking</link>
		<comments>http://www.tapanray.in/witty-promise-is-it-path-breaking/#comments</comments>
		<pubDate>Thu, 19 Feb 2009 04:30:12 +0000</pubDate>
		<dc:creator>Tapan Ray</dc:creator>
				<category><![CDATA[Pharma]]></category>
		<category><![CDATA[Access]]></category>
		<category><![CDATA[affordable]]></category>
		<category><![CDATA[andrew]]></category>
		<category><![CDATA[breaking]]></category>
		<category><![CDATA[differential]]></category>
		<category><![CDATA[GSK]]></category>
		<category><![CDATA[is]]></category>
		<category><![CDATA[path]]></category>
		<category><![CDATA[poor]]></category>
		<category><![CDATA[Pricing]]></category>
		<category><![CDATA[promise]]></category>
		<category><![CDATA[witty]]></category>

		<guid isPermaLink="false">http://tapanray.in/index.php/?p=968</guid>
		<description><![CDATA[The Guardian, Saturday 14 February, 2009 reported that Andrew Witty, the head honcho of GlaxoSmithKline (GSK) strongly believes, “patents are social construct that must rest upon ethical foundation”.Witty with his earlier various ‘out of box’ decisions, appears to gradually establish &#8230; <a href="http://www.tapanray.in/witty-promise-is-it-path-breaking/">Continue reading <span class="meta-nav">&#8594;</span></a>]]></description>
		<wfw:commentRss>http://www.tapanray.in/witty-promise-is-it-path-breaking/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>
